Johnston David Brannon
Chief Financial Officer at ImmunoGen, Inc.; Chief Financial Officer at AVEO PHARMACEUTICALS INC
- Sold, on record
- $1M
- Dollars the filings state
- Form 4 sales
- 16
- Latest Jun 6, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ImmunoGen, Inc.Chief Financial Officer
- AVEO PHARMACEUTICALS INCChief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ImmunoGen, Inc.51,060 shares
- AVEO PHARMACEUTICALS INC31,610 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale AVEO PHARMACEUTICALS INCPlan not statedSep 13 2012
Sold 1,386 shares at $10.60 ($15k)
Johnston David Brannon, Chief Financial Officer
Sold 5.3% of holdings ($275k position)24,593 shares left0.7x usual sizeFiling
- 2 Form 4 sale AVEO PHARMACEUTICALS INCPlan not statedJan 28 +137 days
Sold 1,150 shares at $7.77 ($9k)
Johnston David Brannon, Chief Financial Officer
Sold 2% of holdings ($452k position)57,004 shares left0.6x usual sizeFiling
- 3 Form 4 sale AVEO PHARMACEUTICALS INCPlan not statedMar 14 +45 days
Sold 1,061 shares at $7.34 ($8k)
Johnston David Brannon, Chief Financial Officer
Sold 1.9% of holdings ($418k position)55,943 shares left0.5x usual sizeFiling
- 4 Form 4 sale ImmunoGen, Inc.UnusualAug 3 +872 days
Sold 5,000 shares at $17.04 ($85k)
Johnston David Brannon, Chief Financial Officer
Sold 100% of holdings ($85k position)0 shares leftFirst sale on recordFiling
- 5 Form 4 sale ImmunoGen, Inc.UnusualSep 17 +45 days
Sold 5,000 shares at $15.00 ($75k)
Johnston David Brannon, Chief Financial Officer
Sold 100% of holdings ($75k position)0 shares leftFiling
- 6 Form 4 sale ImmunoGen, Inc.Plan not statedFeb 21 +888 days
Sold 21,060 shares at $10.87 ($229k)
Johnston David Brannon, Chief Financial Officer
Sold 10.4% of holdings ($2.2M position)180,690 shares leftFirst sale on recordFiling
- 7 Form 4 sale ImmunoGen, Inc.Plan not statedMar 15 +22 days
Sold 10,000 shares at $11.53 ($115k)
Johnston David Brannon, Chief Financial Officer
Sold 5.2% of holdings ($2.2M position)180,690 shares leftFiling
- 8 Form 4 sale ImmunoGen, Inc.Plan not statedJun 6 +83 days
Sold 10,000 shares at $11.02 ($110k)
Johnston David Brannon, Chief Financial Officer
Sold 5.2% of holdings ($2.1M position)180,690 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (16)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2018 | ImmunoGen, Inc. | Chief Financial Officer | Form 4 sale | 10,000 | $110k | 5.2% | Plan not stated | SEC |
| Mar 15, 2018 | ImmunoGen, Inc. | Chief Financial Officer | Form 4 sale | 10,000 | $115k | 5.2% | Plan not stated | SEC |
| Feb 21, 2018 | ImmunoGen, Inc. | Chief Financial Officer | Form 4 sale | 21,060 | $229k | 10.4% | Plan not stated | SEC |
| Sep 17, 2015 | ImmunoGen, Inc. | Chief Financial Officer | Form 4 sale | 5,000 | $75k | 100.0% | Unusual | SEC |
| Aug 3, 2015 | ImmunoGen, Inc. | Chief Financial Officer | Form 4 sale | 5,000 | $85k | 100.0% | Unusual | SEC |
| Mar 14, 2013 | AVEO PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,061 | $8k | 1.9% | Plan not stated | SEC |
| Jan 28, 2013 | AVEO PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,150 | $9k | 2.0% | Plan not stated | SEC |
| Sep 13, 2012 | AVEO PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,386 | $15k | 5.3% | Plan not stated | SEC |
| Jun 6, 2012 | AVEO PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 15,000 | $183k | 37.4% | Unusual | SEC |
| Jan 26, 2012 | AVEO PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,107 | $15k | 16.9% | Plan not stated | SEC |
| Dec 1, 2011 | AVEO PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,000 | $17k | 14.3% | Plan not stated | SEC |
| Nov 1, 2011 | AVEO PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 2,000 | $31k | 25.0% | Unusual | SEC |
| Oct 3, 2011 | AVEO PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 2,000 | $31k | 25.0% | Unusual | SEC |
| Sep 1, 2011 | AVEO PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 2,000 | $34k | 25.0% | Unusual | SEC |
| Aug 24, 2011 | AVEO PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 1,906 | $31k | 24.1% | Plan not stated | SEC |
| Aug 1, 2011 | AVEO PHARMACEUTICALS INC | Chief Financial Officer | Form 4 sale | 3,000 | $58k | 27.5% | Unusual | SEC |